bullish

Kanzhun

ECM Weekly (6th June 2021) - Kanzhun, Full Truck, Aihuishou, Angelalign, Del Monte PH, WM, Renesas

259 Views06 Jun 2021 10:37
SUMMARY

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.


The ECM space continued to record a slew of placements this week.

Leading in deal size was Japanese semiconductor manufacturer, Renesas Electronics, looking to raise US$3.4bn via selling a mix of primary and secondary shares. Bookbuild began on Thursday and will close this Tuesday. Proceeds will be used to fund the acquisition of the UK’s Dialog Semiconductor and repay borrowings.

In Hong Kong, undisclosed institutional investors sold about US$341m of shares in Evergrande Property Services right as lock-up expired on Wednesday. We flagged this earlier when China Evergrande Group sold shares in Evergrande New Auto last month.

Metals miner MMG raised US$302m from an upsized placement (up from US$220m). Books were multiple times oversubscribed, with the majority of demand coming from long-only investors. We thought the deal was opportunistic, the shares closed 5.06% below its deal price on Friday.

Warburg Pincus raised US$213m from a sell-down in Hygeia Healthcare. The stock has been holding up well, trading 1.5% above deal price.

In the A-share market, Intco Medical, released a pre-sell down disclosure which stated that its key shareholder and management plan to sell shares in the company. We discussed the implications of the sell-down on its planned US$1bn Hong Kong IPO.

Other placements include C&D International Investment Group which raised US$121.5m to repay loans, expand land reserves, and for general working capital.

For potential placements, JD Health and PopMart are the two IPOs that will see their lock-up expire soon. In both IPOs, investors are sitting on handsome returns and could come to market to sell.

For live IPOs, Kanzhun launched the terms of its bookbuild on Friday and drew interests from reputable financial investors, leaving roughly 60% of deal for other investors.

In Hong Kong, Angelalign launched its US$375m IPO bookbuild on Thursday. Books were reportedly covered an hour later. The deal will price this Tuesday and trade on 16th June.

CARsgen Therapeutics released the terms of its IPO and bookbuild will open on Monday. Shares will trade on 18th June. We covered the IPO earlier in:

Following our coverage on WM Tech, Ming Lu went on the ground to discuss Wumart’s store locations and goods for sale in the supermarkets. WM Tech is aiming to raise US$1bn from its IPO.

In the US, China's Uber for Trucks, Full Truck Alliance, which filed last week and has begun pre-marketing its US$1.5bn IPO.

We also initiated on pre-owned consumer electronics transactions and services platform, Aihuishou, which aims to raise US$1bn. JD.com, its largest shareholder, owns a 34.7% stake and other backers include Morningside and Tiger Global.

Zhangmen Education downsized its IPO deal size from the initial US$100m (placeholder) to US$47m amidst looming regulatory crackdown. We will not be covering the deal further.

In the Philippines, we initiated on F&B producer Del Monte Philippines, which is looking to raise US$791m in its upcoming IPO. In our notes, we discussed the company’s business model and potential HoldCo trade for Del Monte Pacific Limited through this listing.

Monde Nissin's debut had been lackluster, closing 0.7% below its IPO price, which was similar to past Philippines' IPO performance, as discussed in our trading update note.

Accuracy Rate:

Our overall accuracy rate is 73.8% for IPOs and 67.3% for Placements

(Performance measurement criteria is explained at the end of the note)

New IPO filings this week

  • Neusoft Medical Systems (Hong Kong, US$400m)
  • Neusoft Xikang Holdings (Hong Kong, US$400m)
  • South China Vocational Education Group (Hong Kong, >US$100m)
  • Aihuishou (US, US$1bn)

News on Upcoming IPOs

Hong Kong/China

US/China ADRs

India

Others

Analysis on Upcoming IPOs

NameInsight
Hong Kong
Anjuke

Anjuke Pre-IPO - Mixed (Positive and Negative) Developments

Betta Pharma

Betta Pharma (贝达医药) A+H: Tier 2 Player Struggled to Break Out

Broncus

Broncus (堃博医疗) Pre-IPO: Big Potential to Be Tested

ByteDance

ByteDance (字节跳动) IPO: How Jinri Toutiao Paves The Way for a Bigger Empire (Part 1)

ByteDance

ByteDance (字节跳动) Pre-IPO: Why Facebook Should Worry About TikTok

ByteDance

ByteDance (字节跳动) IPO: Tiktok the No.1 Short Video App for a Good Reason (Part 2)

ByteDance

ByteDance (字节跳动) Pre-IPO: How Has It Done in 1H?

ByteDance

ByteDance: The Unlisted Company’s Video Apps Leading the Market and Threatening Internet Giants

ByteDance

ByteDance (字节跳动) Pre-IPO: Why Facebook Should Worry About TikTok

ByteDance

ByteDance (字节跳动) Pre-IPO - Globally the Most Downloaded App for Jan 2020 Driven by India

ByteDance

ByteDance (字节跳动) Pre-IPO: Global Ambition Meets Regulatory Challenges

Chaoju

Chaoju Eye Care (朝聚眼科) Pre-IPO: Growth Prospect Far from Being Impressive

Dida

Dida Pre-IPO - Making Hay While Big Brother Retreats

Dida

Dida Pre-IPO - Earnings Forecast and First Stab at Valuation

Dida

Dida Pre-IPO - Peer Comparison - Lagging in Scale, Leading in Profitability

Edding Grp

Edding Group (亿腾医药) Pre-IPO: Notes from Latest Financials and Its Related Party

Edding Grp

Edding Group (亿腾医药) Pre-IPO: Notes from Latest Financials and Its Related Party

Hanyu

Shanghai Hanyu (捍宇医疗) Pre-IPO: Not a Straight-A but Listing at Right Time

Intco Med

Intco Medical (英科医疗) A+H: From China No.1 to Global No. 1

Kilcoy

Kilcoy Global Foods Pre-IPO - Rapid Earnings Growth on the Back of Margin Improvement

Kilcoy

Kilcoy Global Foods Pre-IPO - A Lot of Things Still Remain Unexplained

Kindstar

Kindstar (康圣环球) Pre-IPO: Issues with Scalability

Kindstar

Kindstar (康圣环球) Pre-IPO: Is It Worth the Premium?

Novotech

Novotech Pre-IPO: Biotech Focused CRO at Hefty Pre-IPO Valuation

RemeGenRemeGen (荣昌生物) Pre-IPO: Thoughts on Valuation of RC18 and RC48
SH Bio-heartShanghai Bio-Heart (上海百心安) Pre-IPO: Needs a Long Runway
ToplistToplist China Pre-IPO - Overwhelmingly More Negatives than Positives
TaslyTasly Biopharm (天士力生物) IPO: Visible Growth from Approved Drug but Lacks Blockbusters
WeDoctorWeDoctor (微医) Pre-IPO -App Walk Through - The Online Medical Directory and More
WeDoctorWeDoctor (微医) Pre-IPO - A More Focused Online Medical Svc Provider than Ping An Good Doctor
WeDoctorWe Doctor (微医) Pre-IPO - Peer Comparison - Picking Its Battles Wisely
WeDoctorWe Doctor (微医) Pre-IPO - Forecasts, Early Thoughts on Valuation, and Acquisition Gripes
WeilongWeilong Delicious Global Pre-IPO - The Positives - Fast Growth, Strong Backers
WeilongWeilong Delicious Global Pre-IPO - The Negatives - Spicy Valuation
WM TechWM Tech Pre-IPO - Digitalization Efforts Coming Through but Not Well Substantiated
Youran DairyChina Youran Dairy(悠然牧业) Pre-IPO - A Leader Pulling Ahead in a Fragmented Market
Youran DairyChina Youran Dairy(悠然牧业) Pre-IPO - PHIP Updates - Much Better Disclosure
Youran DairyChina Youran Dairy(悠然牧业) Pre-IPO - Peer Comparison - Youran Is the Leader
India
Aadhar HousingAadhar Housing Finance Pre-IPO - Decent past Growth but Comes with Weird Disclosures
ASKASK Investment Managers Pre-IPO - Riding on a Wave of Wealth
Anmol IndAnmol Industries Pre-IPO Quick Take - No Growth, Generous Payments to Founders
Bharat Hotel

Bharat Hotels Pre-IPO - Catching up with Peers

Bajaj En

Bajaj Energy Pre-IPO - Supposed to Deliver Steady Performance if Only Its Sole Client Would Let It

CMS InfoCMS Info Systems Pre-IPO - When a PE Sells to Another PE... Only One Gets the Timing Right
Crystal CropCrystal Crop Protection Pre-IPO - DRHP Raises More Questions than in Answers
ESAF SFBESAF Small Finance Bank Pre-IPO - Growing Fast but Remains Highly Dependant on a Related Party
Flemingo Flemingo Travel Retail Pre-IPO - Its a Different Business in Every Country
Emami CemEmami Cement Pre-IPO - Still in Ramp Up Phase but Shares Pledge Might Lead to an Early IPO
NSENSE IPO Preview- Not Only Fast..its Risky and Expensive
NSENational Stock Exchange Pre-IPO Review - Bigger, Better, Stronger but a Little Too Fast for Some

LIC

Life Insurance Corporation of India Pre-IPO - Early Take on India's Largest IPO
Penna CemPenna Cement - Aggressive Expansion Plans Even Though Past Performance Has Been Tepid
PNB MetPNB Metlife Pre-IPO Quick Take - Doesn't Stack up Well Versus Its Larger Peers
Samhi HotelsSamhi Hotels Pre-IPO - Assets and Borrowings Are Growing, but Earnings Haven’t Kept Pace
Sona ComstarSona Comstar Pre-IPO - Inconsistent Growth, Patchy Disclosures
ZomatoZomato Pre-IPO - Filings Lack Narrative, a Little Bit of History Helps
ZomatoZomato Pre-IPO - Food Delivery Revenue Was Probably up 16x
Malaysia
QSRQSR Brands Pre-IPO - As Healthy as Fast Food
The U.S.
ForUForU Worldwide Pre-IPO - Mostly Negatives
Full Truck AllFull Truck Alliance Pre-IPO - The Positives - Category Leader
Full Truck AllFull Truck Alliance Pre-IPO - The Negatives - Still a Mixed Bag
Hello IncHello Inc (哈罗出行) Pre-IPO - Nowhere near Being Sustainable
SoulgateSoulgate Pre-IPO - Unsustainable Virtual Connection
QiniuQiniu Cloud (七牛云) Pre-IPO: PaaS Doesn't Warrant a Premium
XimalayaXimalaya Pre-IPO - The Positives - A Whole Lot of Listening
XimalayaXimalaya Pre-IPO - The Negatives
XimalayaXimalaya Pre-IPO - Peer Comparison
XimalayaXimalaya Pre-IPO - Earnings Forecast and Valuation
XimalayaXimalaya (XIMA): Has Large Market Share, But Small Competitors Have Big Bosses.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
x